Who owns LB PHARMACEUTICALS INC?
- CUSIP Number: 50180m108
Tip: Access positions for across all investors
Analyze quarterly positions in Lb Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lb Pharmaceuticals stock
Who bought or sold LB PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 3.4M | $53M | 100% | Sep 2025 |
|
| RA Capital Management | 1.8M | $28M | 100% | Sep 2025 |
|
| TCG Crossover Management | 1.7M | $28M | 100% | Sep 2025 |
|
| Commodore Capital | 1.5M | $24M | 100% | Sep 2025 |
|
| Logos Global Management | 1.1M | $18M | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 1.0M | $16M | 100% | Sep 2025 |
|
| BlackRock | 975k | $15M | 100% | Sep 2025 |
|
| Balyasny Asset Management | 968k | $15M | 100% | Sep 2025 |
|
| Vivo Capital | 800k | $13M | 100% | Sep 2025 |
|
| Jennison Associates | 739k | $12M | 100% | Sep 2025 |
|
| Alyeska Investment Group | 675k | $11M | 100% | Sep 2025 |
|
| Nantahala Capital Management | 675k | $11M | 100% | Sep 2025 |
|
| Citadel Advisors | 539k | $8.5M | 100% | Sep 2025 |
|
| Millennium Management | 538k | $8.5M | 100% | Sep 2025 |
|
| Soleus Capital Management | 400k | $6.3M | 100% | Sep 2025 |
|
| FMR | 369k | $5.8M | 100% | Sep 2025 |
|
| Wellington Management Company | 345k | $5.4M | 100% | Sep 2025 |
|
| Goldman Sachs Group | 344k | $5.4M | 100% | Sep 2025 |
|
| Nan Fung Group Holdings | 300k | $4.7M | 100% | Sep 2025 |
|
| Marshall Wace | 256k | $4.0M | 100% | Sep 2025 |
|
| Adage Capital Partners GP | 200k | $3.2M | 100% | Sep 2025 |
|
| Baker Bros. Advisors | 200k | $3.2M | 100% | Sep 2025 |
|
| Integral Health Asset Management | 100k | $1.6M | 100% | Sep 2025 |
|
| Ameriprise Financial | 78k | $1.2M | 100% | Sep 2025 |
|
| Boxer Capital Management | 70k | $1.1M | 100% | Sep 2025 |
|
| Silverarc Capital Management | 70k | $1.1M | 100% | Sep 2025 |
|
| Hrt Financial | 59k | $928k | 100% | Sep 2025 |
|
| Monashee Investment Management | 40k | $632k | 100% | Sep 2025 |
|
| TD Asset Management | 37k | $581k | 100% | Sep 2025 |
|
| Point72 | 34k | $537k | 100% | Sep 2025 |
|
| Barclays | 31k | $487k | 100% | Sep 2025 |
|
| Jane Street | 30k | $486k | 100% | Sep 2025 |
|
| Longwood Capital Partners | 30k | $474k | 100% | Sep 2025 |
|
| Hudson Bay Capital Management | 27k | $428k | 100% | Sep 2025 |
|
| Squarepoint Ops | 21k | $329k | 100% | Sep 2025 |
|
| Oxford Asset Management | 18k | $281k | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 18k | $276k | 100% | Sep 2025 |
|
| Aristeia Capital | 15k | $241k | 100% | Sep 2025 |
|
| Point72 Asia | 15k | $230k | 100% | Sep 2025 |
|
| Geode Capital Management | 14k | $215k | 100% | Sep 2025 |
|
| Two Sigma Investments | 14k | $213k | 100% | Sep 2025 |
|
| Brevan Howard Capital Management | 13k | $209k | 100% | Sep 2025 |
|
| Leucadia National Corporation | 13k | $207k | 100% | Sep 2025 |
|
| XTX Topco | 11k | $178k | 100% | Sep 2025 |
|
| Landscape Capital Management | 11k | $168k | 100% | Sep 2025 |
|
| Federated Investors | 9.0k | $142k | 100% | Sep 2025 |
|
| UBS Group | 1.1k | $17k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 1.0k | $16k | 100% | Sep 2025 |
|
| Quarry | 11.00 | $174.000200 | 100% | Sep 2025 |
|